CRP and chronic lung disease: A recent multi-site double-blind, placebo controlled, randomized controlled trial showed that a 48-week weekly azithromycin treatment significantly reduced C reactive protein (CRP), MMP10, and neutrophil adhesion molecule E-selectin serum levels in individuals aged 6–19 years with HIV-associated chronic lung disease [85].